MedPath

Study Where Healthy Volunteers Evaluate LoFric Catheters

Not Applicable
Completed
Conditions
Catheterization
Interventions
Device: LoFric POBE
Registration Number
NCT00802750
Lead Sponsor
Wellspect HealthCare
Brief Summary

The purpose of this study is to evaluate healthy volunteers perception of catheterization with LoFric catheters with new solvents in the manufacturing process. The subjects will be catheterized three times during one visit day.

The hypothesis is that the subjects' perception of catheterization is the same when using the test catheters compared to the reference catheter.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
25
Inclusion Criteria
  • Provision of written informed consent
  • Healthy volunteers
  • Males age 18 years and over
Exclusion Criteria
  • Known or suspected, current impairment of and/or decreased urethral sensibility
  • History of urethral disease
  • History of urinary tract infection within three months, or ongoing symptomatic urinary tract infection
  • Use of medications that may affect the urethra's dryness (e. g. anti-cholinergic drugs or cortisone)
  • Current drug, alcohol or other substance abuse
  • Other significant disease or condition (e.g. benign prostate hypertrophy, other prostatic lesions), which may interfere with treatment and/or evaluation
  • Allergy to Trimethoprim
  • Suspected poor compliance with the protocol during the complete study period.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
BLoFric POBE-
ALoFric POBE-
Primary Outcome Measures
NameTimeMethod
Healthy volunteers perception of catheterizationAt each catheterization (three times during one day)
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Clinical Research and Trial Centre, Lund University Hospital

🇸🇪

Lund, Sweden

© Copyright 2025. All Rights Reserved by MedPath